🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/05/2024 | 128,84 | 129,08 | 125,74 | 126,09 | -2,63% | 2,59% | 10.263.400 |
| 24/05/2024 | 131,45 | 131,45 | 129,16 | 129,49 | -1,22% | 1,74% | 5.983.800 |
| 23/05/2024 | 130,90 | 131,92 | 130,31 | 131,09 | -0,01% | 1,23% | 6.830.900 |
| 22/05/2024 | 130,17 | 131,60 | 130,15 | 131,10 | +0,26% | 1,11% | 4.407.500 |
| 21/05/2024 | 131,68 | 132,79 | 130,48 | 130,76 | -0,18% | 1,75% | 6.254.700 |
| 20/05/2024 | 130,81 | 131,74 | 130,65 | 130,99 | -0,15% | 0,83% | 4.860.400 |
| 17/05/2024 | 130,69 | 131,32 | 129,81 | 131,19 | +0,24% | 1,16% | 8.281.600 |
| 16/05/2024 | 131,37 | 131,78 | 130,79 | 130,88 | -0,65% | 0,75% | 5.518.100 |
| 15/05/2024 | 128,88 | 131,97 | 128,72 | 131,73 | +2,39% | 2,52% | 7.237.100 |
| 14/05/2024 | 129,20 | 129,20 | 128,03 | 128,66 | -0,49% | 0,91% | 6.154.300 |
| 13/05/2024 | 129,51 | 129,71 | 128,02 | 129,29 | -0,59% | 1,30% | 7.109.700 |
| 10/05/2024 | 130,82 | 130,88 | 129,95 | 130,06 | -0,13% | 0,71% | 5.722.600 |
| 09/05/2024 | 128,94 | 130,50 | 128,94 | 130,23 | +0,52% | 1,21% | 9.216.700 |
| 08/05/2024 | 130,58 | 131,51 | 129,33 | 129,55 | -0,64% | 1,67% | 6.659.100 |
| 07/05/2024 | 127,10 | 130,43 | 127,07 | 130,38 | +2,20% | 2,64% | 6.682.300 |
| 06/05/2024 | 127,18 | 127,73 | 126,76 | 127,57 | +0,05% | 0,76% | 6.552.000 |
| 03/05/2024 | 128,01 | 128,48 | 127,18 | 127,51 | -0,58% | 1,02% | 6.221.900 |
| 02/05/2024 | 129,06 | 129,69 | 127,99 | 128,26 | -0,42% | 1,32% | 7.422.500 |
| 01/05/2024 | 128,61 | 129,93 | 127,80 | 128,80 | -0,33% | 1,66% | 5.895.700 |
| 30/04/2024 | 130,92 | 130,92 | 128,98 | 129,22 | -0,69% | 1,48% | 6.945.000 |
| 29/04/2024 | 131,72 | 132,20 | 129,33 | 130,12 | -0,82% | 2,18% | 6.788.000 |
| 26/04/2024 | 130,13 | 131,91 | 130,13 | 131,20 | +0,37% | 1,37% | 7.758.200 |
| 25/04/2024 | 129,69 | 132,80 | 128,76 | 130,72 | +2,93% | 3,12% | 12.750.100 |
| 24/04/2024 | 126,82 | 127,59 | 125,35 | 127,00 | +0,09% | 1,77% | 7.128.300 |
| 23/04/2024 | 128,10 | 128,10 | 126,74 | 126,88 | -0,05% | 1,06% | 7.744.000 |
| 22/04/2024 | 126,71 | 128,08 | 126,22 | 126,94 | +0,92% | 1,47% | 7.805.800 |
| 19/04/2024 | 125,65 | 126,12 | 124,89 | 125,78 | +0,44% | 0,98% | 8.404.300 |
| 18/04/2024 | 125,52 | 125,52 | 124,50 | 125,23 | -0,11% | 0,81% | 5.992.700 |
| 17/04/2024 | 125,67 | 126,19 | 124,71 | 125,37 | +0,25% | 1,18% | 6.122.800 |
| 16/04/2024 | 126,56 | 126,80 | 125,03 | 125,06 | -0,90% | 1,40% | 5.587.300 |